277 related articles for article (PubMed ID: 25961064)
1. Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.
Franz BJ; Li Y; Bitsaktsis C; Iglesias BV; Pham G; Sunagar R; Kumar S; Gosselin EJ
J Immunol Res; 2015; 2015():840842. PubMed ID: 25961064
[TBL] [Abstract][Full Text] [Related]
2. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
3. Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.
Pham GH; Iglesias BV; Gosselin EJ
Vaccine; 2014 Sep; 32(40):5212-20. PubMed ID: 25068496
[TBL] [Abstract][Full Text] [Related]
4. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.
Rawool DB; Bitsaktsis C; Li Y; Gosselin DR; Lin Y; Kurkure NV; Metzger DW; Gosselin EJ
J Immunol; 2008 Apr; 180(8):5548-57. PubMed ID: 18390739
[TBL] [Abstract][Full Text] [Related]
5. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.
Sunagar R; Kumar S; Franz BJ; Gosselin EJ
Vaccine; 2016 Jun; 34(29):3396-404. PubMed ID: 27182819
[TBL] [Abstract][Full Text] [Related]
6. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
7. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
9. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
Melillo AA; Foreman O; Bosio CM; Elkins KL
Infect Immun; 2014 Apr; 82(4):1477-90. PubMed ID: 24421047
[TBL] [Abstract][Full Text] [Related]
10. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
[TBL] [Abstract][Full Text] [Related]
11. FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes.
Duffy EB; Periasamy S; Hunt D; Drake JR; Harton JA
J Leukoc Biol; 2016 Dec; 100(6):1335-1347. PubMed ID: 27365531
[TBL] [Abstract][Full Text] [Related]
12. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
[TBL] [Abstract][Full Text] [Related]
13. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
14. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
15. Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection.
Furuya Y; Kirimanjeswara GS; Roberts S; Metzger DW
Infect Immun; 2013 Sep; 81(9):3434-41. PubMed ID: 23836815
[TBL] [Abstract][Full Text] [Related]
16. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
[TBL] [Abstract][Full Text] [Related]
18. An
Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
[No Abstract] [Full Text] [Related]
19. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
Roberts LM; Davies JS; Sempowski GD; Frelinger JA
Vaccine; 2014 Jun; 32(29):3595-603. PubMed ID: 24837506
[TBL] [Abstract][Full Text] [Related]
20. In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.
Bitsaktsis C; Babadjanova Z; Gosselin EJ
Infect Immun; 2015 Jan; 83(1):77-89. PubMed ID: 25312957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
